Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women

E Soh, Soh Eiki, Kodo Sato, K Sato
Cancer · 1990 · vol. 66(5) , pp. 983–988 · doi:10.1002/1097-0142(19900901)66:5<983::aid-cncr2820660530>3.0.co;2-6 · PMID:2386926 · W2028130420
Case report OA: bronze CC0 ⤵ 12 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-11 ⓘ

Danazol treatment of 15 menopausal and postmenopausal women with endometrial hyperplasia led to regression of hyperplastic endometrium within 2-3 months without recurrence or progression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Much evidence has been suggested that cystic, adenomatous, and atypical hyperplasia as well as adenocarcinoma in situ of the endometrium may ultimately progress to invasive cancer. Consequently, these lesions should be considered to be precursors of endometrial cancer. Twelve postmenopausal and three perimenopausal women with vaginal bleeding due to endometrial hyperplasia received 400 mg/d of danazol orally for 3 months. After 15 to 30 days of continuous danazol therapy, the endometrial glands ceased to grow and became smaller and rounder. The lumina of glands were narrow and contained no secretion. The nucleic mitosis of the glands disappeared. All women showed regression of hyperplastic endometrium within 2 to 3 months of initial treatment. In the 15 cases treated, endometrial hyperplasia could be controlled successfully with danazol without further recurrence and/or progression of the disease. In summary, danazol should be an effective and safe alternative therapy to progesterone for the treatment of endometrial hyperplasia.

My notes (saved in your browser only)

MeSH descriptors

Danazol Endometrial Hyperplasia Menopause Pregnadienes Aged Danazol Drug Evaluation Endometrial Hyperplasia Endometrial Hyperplasia Female Follow-Up Studies Humans Middle Aged Pregnadienes Uterine Hemorrhage Uterine Hemorrhage

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (4)

Cited by (9)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:12:19.954899+00:00
License: CC0 · commercial use OK